Brooks Gabriel — SEC Form 4 filings
SEC reporting owner CIK 1997809. 10 Form 4 filings on record with FilingPulse; latest filed 2026-04-21.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-16 to 2026-04-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 50,025 shares, $312,808 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 28,335 shares @ $6.44 ($182,390) in Solid Biosciences Inc., filed 2026-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | Chief Medical Officer | 10 | — | 6 legs · 50,025 sh · $312,808 | 20 |
Form 4 filings — Brooks Gabriel
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-21 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 58,847 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 10,937 · Sale (S): 0 @ $5.82 · Option exercise (M): 10,937 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Solid Biosciences Inc. (SLDB) | Sale (S): 12,616 @ $6.44 | EDGAR |
| 2026-02-02 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 58,847 · Option exercise (M): 28,225 · Sale (S): 28,335 @ $6.44 · Option exercise (M): 58,847 (derivative) @ $0 · Grant/award (A): 207,450 (derivative) @ $0 · Grant/award (A): 103,750 (derivative) @ $0 · +1 more | EDGAR |
| 2025-10-21 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 9,750 · Sale (S): 2,895 @ $5.96 · Option exercise (M): 9,750 (derivative) @ $0 | EDGAR |
| 2025-08-18 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 142,500 (derivative) @ $0 · Grant/award (A): 71,250 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 10,937 · Sale (S): 3,256 @ $3.96 · Option exercise (M): 10,937 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 112,900 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 9,750 · Sale (S): 2,923 @ $6.50 · Option exercise (M): 9,750 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 87,500 (derivative) @ $0 · Grant/award (A): 43,750 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1997809 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →